---
order: 993
---

# Phase 2 Clinical Data Submission

## Overview
In HTAN Phase 2, there are two clinical metadata tiers. 
- Tier 1 metadata is divided into multiple categories, including Demographics, Diagosis, Family History, Exposure, Molecular Test, Therapy, Follow Up and Vital Status. 
- Tier 2 contains any cancer or study-specific clinical information which is not represented in Tier 1. Tier 2 is a flexible comma-separated value (csv) file. The only required attribute is HTAN Participant ID. All other attributes (columns headers) are determined by the submitting Center. 

Figure 2 provides a general representation of the model. 

![Figure 2. HTAN Phase 2 Clinical Metadata Tiers](../img/Phase2_clinical_data_tiers.svg)

This page provides additional details regarding submission of Phase 2 Clinical Data. 

!!! Terminology:
This document uses the following terms from IEFT RFC 2119

MUST / REQUIRED / SHALL:  âœ… (denotes absolute requirement)

MUST NOT / SHALL NOT: âŒ (denotes absolute prohibition)

SHOULD / RECOMMENDED: ğŸŒŸ (denotes recommendation)

SHOULD NOT / NOT RECOMMENDED: ğŸ™…â€â™‚ï¸ (denotes not recommended)

MAY / OPTIONAL: ğŸ¤·â€â™€ï¸ (denotes optional) 
!!!

All HTAN data elements that capture time points are expressed as â€œdays toâ€ to obfuscate dates while allowing for longitudinal timelines and relative data analysis.  The index date for all HTAN dates is the participant date of birth.  For example, if a patient has therapy starting at X=365 days, that means the therapy started 365 days after birth. 

The data standards allow for multiple responses for many data elements.  This information may be found in the â€œValidationâ€ column of the HTAN Data Model documentation. Multiple responses are submitted delimited by commas.

## Clinical Tier 1: Demographics
Clinical Tier 1 Demographics data includes patient attributes captured at baseline or at the time of the cross-sectional observation. These data include ethnicity, race, etc. </br>
âœ…	A single Demographics record is REQUIRED for each HTAN participant. </br>
âŒ	A single HTAN participant MUST NOT have multiple demographics records. </br> 

## Clinical Tier 1: Diagnosis
Clinical Tier 1 Diagnosis data elements describe the HTAN participantâ€™s incident tumor or premalignant lesion (PML). These data include primary diagnosis, anatomic site of the tumor or PML, and classification and grade of the lesion.</br>
âœ…	A single Diagnosis record is REQUIRED for each PML or tumor.</br>
âœ…	All dates (â€˜Age in Days at Diagnosisâ€™, â€˜Age in Days at Last Known Disease Statusâ€™) MUST be converted to days from index, where the index is the participant date of birth.</br>
ğŸŒŸ	If a participant develops a new lesion or has/had a secondary cancer, a new Diagnosis record (row) SHOULD be added to the Diagnosis manifest. In all other cases, each participant SHOULD have only one Diagnosis record. </br>

## Clinical Tier 1: Exposure
Clinical Tier 1 Exposure data elements describe the HTAN participantâ€™s exposure to tobacco products, alcohol and other environmental exposure. These data include alcohol exposure, smoking history, years smoked, pack years smoked, and environmental exposure type.</br>
ğŸŒŸ	An Exposure record SHOULD be submitted to document the HTAN participantâ€™s smoke or other exposure at baseline or at the time of observation in a cross-sectional study.  </br>
ğŸŒŸ	Clinical Tier 2 SHOULD be used to submit additional exposure data consistent with a publication or other documentation, if needed.

## Clinical Tier 1: Family History
Clinical Tier 1 Family History data elements capture the incidence of cancer in an HTAN participantâ€™s family. These data include the family memberâ€™s primary diagnosis and age at diagnosis.</br>
ğŸŒŸ	A single Family History record SHOULD be submitted for each participant. </br>
ğŸŒŸ  All family members affected are provided in a comma-separated list in the participant.</br>
ğŸŒŸ	Clinical Tier 2 SHOULD be used to submit more extensive family history data, if needed.



